Literature DB >> 20551869

Transition: a rheumatology perspective.

Rachel Tattersall1, Janet E McDonagh.   

Abstract

This article reviews the evidence regarding the process of transition which young people experience when moving from paediatric to adult care. Rheumatology has championed this process and this article prioritizes the perspective of adult physicians.

Entities:  

Mesh：

Year:  2010        PMID： 20551869     DOI： 10.12968/hmed.2010.71.6.48439

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN： 1750-8460            Impact factor:   0.825


  6 in total

1.  Growing up: the role of the Royal College of Physicians.

Authors:  Janet E McDonagh; Angela J Robinson
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  Attitudes of rheumatology practitioners toward transition and transfer from pediatric to adult healthcare.

Authors:  Deborah Hilderson; Philip Moons; Rene Westhovens; Carine Wouters
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

3.  Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.

Authors:  Yvette Leung; Melvin B Heyman; Uma Mahadevan
Journal:  Inflamm Bowel Dis       Date:  2010-12-16       Impact factor: 5.325

4.  Looking through the patient lens - Improving best practice for young people with juvenile idiopathic arthritis transitioning into adult care.

Authors:  Samantha Howland; Kay Fisher
Journal:  Springerplus       Date:  2015-03-05

5.  Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices.

Authors:  Rebecca E Sadun; Laura E Schanberg
Journal:  Lupus Sci Med       Date:  2018-08-13

6.  Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases.

Authors:  Margot Walter; Sylvia Kamphuis; Philomine van Pelt; Annemarie de Vroed; Johanna M W Hazes
Journal:  Pediatr Rheumatol Online J       Date:  2018-08-03       Impact factor: 3.054
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.